Aclaris Therapeutics News

Aclaris Therapeutics | ARS: Annual Report to Security Holders

Apr 25 07:05 ET

Aclaris Therapeutics | DEFA14A: Others

Apr 25 07:05 ET

Aclaris Therapeutics | DEF 14A: Definitive information statements

Apr 25 07:05 ET

Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal

Apr 3 17:05 ET

Aclaris Therapeutics | 8-K: Current report

Mar 19 16:33 ET

Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Balthaser Kevin

Mar 5 17:13 ET

Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Monahan Joseph

Mar 5 17:12 ET

Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Walker Neal

Mar 5 17:09 ET

Aclaris Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Powell Andrew Kenneth William

Mar 5 17:05 ET

Aclaris Therapeutics | 10-K: Annual report

Feb 27 07:35 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Feb 27 07:20 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(0.0%),VHCP Co-Investment Holdings II, LLC(0.0%), etc.

Feb 14 20:33 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.

Feb 14 17:30 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(7.6%),Citadel Advisors LLC(6.1%), etc.

Feb 14 17:05 ET

Aclaris Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%), etc.

Feb 14 16:22 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(2.5%),Tang Capital Management, LLC(2.5%), etc.

Feb 14 16:03 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rock Springs Capital Management LP(4.23%),Rock Springs Capital LLC(4.23%), etc.

Feb 14 15:51 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.

Feb 14 10:32 ET

Aclaris Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(6.67%)

Feb 13 18:18 ET

Aclaris Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Foresite Capital Fund IV, L.P. (“FCF IV”)(0.0%),Foresite Capital Management IV, LLC (“FCM IV”)(0.0%), etc.

Feb 13 14:26 ET